FCI
ABBV icon

Financial Counselors Inc’s AbbVie ABBV Stock Holding History

Financial Counselors Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-471,579
Closed -$98.8M – 16
2025
Q1 		$98.8M Buy
471,579
+1,391
+0.3% +$270K 1.5% 10
2024
Q4 		$83.6M Sell
470,188
-6,119
-1% -$1.13M 1.22% 11
2024
Q3 		$94.1M Buy
476,307
+4,500
+1% +$840K 1.39% 11
2024
Q2 		$80.9M Buy
471,807
+8,067
+2% +$1.34M 1.3% 11
2024
Q1 		$84.4M Buy
463,740
+31,375
+7% +$5.41M 1.42% 9
2023
Q4 		$67M Buy
432,365
+1,048
+0.2% +$153K 1.2% 11
2023
Q3 		$64.3M Buy
431,317
+3,285
+0.8% +$482K 1.29% 10
2023
Q2 		$57.7M Buy
428,032
+1,895
+0.4% +$278K 1.17% 14
2023
Q1 		$67.9M Sell
426,137
-2,494
-0.6% -$381K 1.46% 7
2022
Q4 		$69.3M Sell
428,631
-936
-0.2% -$144K 1.55% 6
2022
Q3 		$57.7M Buy
429,567
+1,068
+0.2% +$153K 1.42% 8
2022
Q2 		$65.6M Sell
428,499
-24,014
-5% -$3.67M 1.53% 6
2022
Q1 		$73.4M Buy
452,513
+11,119
+3% +$1.62M 1.52% 6
2021
Q4 		$59.8M Sell
441,394
-27,144
-6% -$3.21M 1.23% 11
2021
Q3 		$50.5M Buy
468,538
+12,785
+3% +$1.46M 1.08% 13
2021
Q2 		$51.3M Buy
455,753
+6,843
+2% +$771K 1.12% 14
2021
Q1 		$48.6M Buy
448,910
+951
+0.2% +$102K 1.13% 13
2020
Q4 		$48M Buy
447,959
+27,108
+6% +$2.61M 1.21% 10
2020
Q3 		$36.9M Buy
420,851
+30,237
+8% +$2.85M 1.08% 16
2020
Q2 		$38.4M Buy
390,614
+65,441
+20% +$5.76M 1.23% 9
2020
Q1 		$24.8M Buy
325,173
+29,919
+10% +$2.55M 1.1% 19
2019
Q4 		$26.1M Buy
295,254
+25,052
+9% +$2.08M 0.93% 21
2019
Q3 		$20.5M Buy
270,202
+23,627
+10% +$1.62M 0.8% 31
2019
Q2 		$17.9M Buy
246,575
+14,130
+6% +$1.11M 0.73% 39
2019
Q1 		$18.7M Buy
232,445
+13,881
+6% +$1.14M 0.8% 31
2018
Q4 		$20.1M Sell
218,564
-2,949
-1% -$259K 0.99% 18
2018
Q3 		$21M Buy
221,513
+16,307
+8% +$1.55M 0.92% 23
2018
Q2 		$19M Buy
205,206
+10,312
+5% +$1.01M 0.88% 23
2018
Q1 		$18.4M Sell
194,894
-39,524
-17% -$4.34M 0.88% 22
2017
Q4 		$22.7M Sell
234,418
-18,936
-7% -$1.78M 1.04% 16
2017
Q3 		$22.5M Sell
253,354
-514
-0.2% -$39.1K 1.1% 11
2017
Q2 		$18.4M Buy
253,868
+3,609
+1% +$243K 0.91% 22
2017
Q1 		$16.3M Buy
250,259
+8,476
+4% +$533K 0.83% 25
2016
Q4 		$15.1M Buy
+241,783
New +$14.8M 0.81% 25
2016
Q2 		$14.1M Buy
227,196
+9,544
+4% +$582K 0.84% 25
2016
Q1 		$12.4M Sell
217,652
-2,740
-1% -$153K 0.77% 27
2015
Q4 		$13.1M Buy
220,392
+36,338
+20% +$2.09M 0.84% 24
2015
Q3 		$10M Buy
184,054
+31,661
+21% +$2.06M 0.69% 37
2015
Q2 		$10.2M Buy
152,393
+7,278
+5% +$475K 0.65% 36
2015
Q1 		$8.49M Buy
145,115
+77,446
+114% +$4.68M 0.53% 53
2014
Q4 		$4.43M Buy
67,669
+2,270
+3% +$143K 0.28% 118
2014
Q3 		$3.78M Buy
65,399
+1,358
+2% +$75.4K 0.26% 122
2014
Q2 		$3.61M Sell
64,041
-2,478
-4% -$130K 0.25% 123
2014
Q1 		$3.42M Buy
66,519
+2,101
+3% +$106K 0.25% 131
2013
Q4 		$3.4M Buy
64,418
+189
+0.3% +$9.29K 0.26% 128
2013
Q3 		$2.87M Sell
64,229
-1,559
-2% -$69.1K 0.24% 139
2013
Q2 		$2.72M Buy
+65,788
New +$2.88M 0.23% 140

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Financial Counselors Inc's ABBV Position: Q2 2025 in Review

Financial Counselors Inc sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 471,579 shares — an estimated $98.8M sold.

Financial Counselors Inc first reported a position in ABBV in Q2 2013 and held it in 47 quarters. The position peaked at $98.8M in Q1 2025. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Financial Counselors Inc reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 471,579 AbbVie shares in Q2 2025, an estimated $98.8M.
  • Financial Counselors Inc first reported a position in AbbVie in Q2 2013 and held it in 47 quarters.
  • Financial Counselors Inc's AbbVie position peaked at $98.8M in Q1 2025.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.